An interventional study of Squat Exercise in Sarcopenia, sponsored by Tzu Chi University. Recruiting at 1 site in Taiwan. Open to participants aged 65 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-24.
Sponsored by Tzu Chi University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 96 studies in Sarcopenia with a site in Taiwan — 30 open to participants now, 31 under way, none of them phase 3. Sarcopenia · Taiwan.
Among the 96 studies in Sarcopenia with a site in Taiwan, this one is the 31st largest by planned enrollment of the 67 interventional ones that give a count, is one of 10 that started in 2026, is one of 63 with no phase, reaches primary completion later than 18 of the 30 other live ones, and was the 91st registered.
1,334 studies on the registry are indexed under Sarcopenia; 418 are open to participants now.
Browse Sarcopenia studies →30 of the 96 studies in Sarcopenia with a site in Taiwan are open now. Recruiting first, the newest first:
Taipei Medical University Hospital · Sites in Taiwan
Ages 60+
yueh chu wu · Sites in Taiwan
Ages 45–85
Valeria Chiu · Sites in Taiwan
Ages 18+ · Women only
National Health Research Institutes, Taiwan · Sites in Taiwan
Ages 40+ · Healthy volunteers
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 50–99
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 246 Sarcopenia studies recruiting now, 155 (63%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 62 take healthy volunteers.
This study: 65 Years to 100 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
96 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 10 started in 2026.
This study's planned enrollment of 80 is above the median of 60 across 860 interventional studies indexed under Sarcopenia.
Median enrollment 80 across the 67 interventional studies, 151 across the 29 observational. Of the 51 that completed or were terminated, 4 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 96 have an industry lead sponsor. The 10 most frequent:
Tzu Chi University is the lead sponsor of 20 studies on the registry; 4 are open to participants now.
Tzu Chi University has 1 study filed under Sarcopenia — fewer than ten, so there is no comparison to draw.
7 of the studies in Sarcopenia with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07830472Taipei Medical University HospitalLower-Limb Rehabilitation Robot Training for Sarcopenia | 2026-12 |
| NCT02635022National Taiwan University HospitalFragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study | 2026-12 |
| NCT07815158National Yang Ming Chiao Tung UniversityMulti-Component Nutrition, Intrinsic Capacity, and Physical Function in Older Adults | 2026-12-15 |
| NCT07726758Tzu Chi UniversityThe Effectiveness of Squat Exercise for Improving Pre-Sarcopenia in Order Adults | 2026-12-31 |
| NCT07465393Valeria ChiuFacility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors | 2027-04-30 |
Add all 7 to your calendar (.ics) → With an account.
Among the 96 studies in Sarcopenia with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
With the growing aging population, it has been reported that approximately 10-20% of older adults have pre-sarcopenia. Pre-sarcopenia is defined as a decline in either muscle mass or muscle strength. Previous studies have indicated that squat exercise has significant effects on improving lower-extremity muscle strength and physical performance. Early intervention through resistance exercise during the pre-sarcopenia stage may increase muscle mass, enhance physical performance, and prevent progression to sarcopenia. Therefore, the purpose of this study is to investigate the effects of squat exercise on improving pre-sarcopenia among older adults. It is expected that, following the squat exercise intervention, older adults will demonstrate significant improvements in muscle mass, lower-extremity muscle strength, physical performance, and body composition, thereby alleviating pre-sarcopenia.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The researcher first assists participants in completing the questionnaire and measures older adults' InBody composition, grip strength, and SPPB (Short Physical Performance Battery). A 12-week squat exercise intervention is then implemented. Post-intervention assessments are conducted at Week 6 and Week 12.
Behavioral: Squat Exercise
No specific resistance training is performed, and participants maintain their usual daily activities.
Squat exercise is an effective resistance training intervention that enhances lower-extremity muscle strength, physical performance, and functional ability, thereby helping prevent or delay sarcopenia in older adults.
Physical performance assessed by the Short Physical Performance Battery (SPPB)
Physical performance will be assessed using the Short Physical Performance Battery (SPPB). The SPPB consists of three components: balance test, gait speed test, and chair stand test. Total scores range from 0 to 12 points, with higher scores indicating better physical performance
Time frame: Baseline, 6 weeks, and 12 weeks
Body composition assessed by bioelectrical impedance analysis (InBody)
Body composition will be assessed using bioelectrical impedance analysis (InBody).Measurements include skeletal muscle mass, body fat mass, and body fat percentage.
Time frame: Baseline, 6 weeks, and 12 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Dec 2026, 9 months after the start.
Of 497 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's planned 9 months is below that.
Counting every sponsor, half of 509 studies reached it within 18 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tzu Chi University